Current perspectives in sleep-disordered breathing

Poster Discussion
Chairs: D. Testelmans (Leuven, Belgium), I. Almendros (Barcelona, Spain)

Electrical stimulation as treatment for obstructive sleep apnoea: a meta-analysis C. Ratneswaran (London, United Kingdom), A. Guni (London, United Kingdom), M. Al-Sherif (London, United Kingdom), M. Pengo (London, United Kingdom), M. Cheng (London, United Kingdom), B. He (London, United Kingdom), J. Steier (London, United Kingdom), E. Schwarz (London, United Kingdom)
Daytime predictors of nocturnal hypoxemia and the role of noninvasive ventilation in the management of patients with amyotrophic lateral sclerosis. A. Galanou (Alxandroupoli, Greece), M. Agrafiotis (Alexandroupoli, Greece), K. Nikolaou (Alexandroupoli, Greece), M. Papathanasiou (Thessaloniki, Greece), A. Chloros (Thessaloniki, Greece), P. Steiropoulos (Alexandroupoli, Greece)
Endocrine responses during CPAP-withdrawal in obstructive sleep apnea: data from two randomised controlled trials. S. Thiel (Zurich, Switzerland), S. Haile (Zurich, Switzerland), M. Peitzsch (Dresden, Germany), E. Schwarz (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), S. Kurth (Zurich, Switzerland), F. Beuschlein (Zurich, Switzerland), M. Kohler (Zurich, Switzerland), T. Gaisl (Zurich, Switzerland)
Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial S. Baillieul (Grenoble, France), B. Wuyam (Grenoble, France), R. Tamisier (Grenoble, France), S. Bailly (Grenoble, France), M. Benmerad (Grenoble, France), S. Vergès (Grenoble, France), D. Perennou (Grenoble, France), J. Pépin (Grenoble, France)
Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea J. Pépin (Grenoble, France), R. Schwab (Philadelphia, United States of America), C. Shapiro (Toronto, Canada), J. Hedner (Gothenburg, Sweden), M. Ahmed (Cleveland, United States of America), N. Foldvary-Schaefer (Cleveland, United States of America), P. Strollo (Pittsburgh, United States of America), G. Mayer (Schwalmstadt/Marburg, Germany), K. Sarmiento (San Francisco, United States of America), M. Baladi (Palo Alto, United States of America), P. Chandler (Palo Alto, United States of America), L. Lee (Palo Alto, United States of America), A. Malhotra (La Jolla, United States of America)
GAD1 polymorphism is associated with obstructive sleep apnea in asthma patients E. Sheludko (Blagoveshchensk, Russian Federation), D. Naumov (Blagoveshchensk, Russian Federation), O. Kotova (Blagoveshchensk, Russian Federation), D. Gassan (Blagoveshchensk, Russian Federation), J. Perelman (Blagoveshchensk, Russian Federation)
Obstructive sleep apnoea screening in the truck driver population L. Roberti (Roma, Italy), C. Causarano (Roma, Italy), P. Prosperi (Pescara, Italy), T. Mastrogiacomo (Bari, Italy), F. Federtrasporti (Bologna, Italy), G. Insalaco (Palermo, Italy)
Association of obstructive sleep apnea syndrome and idiopathic pulmonary fibrosis: in vitro and in vivo study based on physical characteristics J. Frija-Masson (Paris, France), K. Zhu (Gentilly, France), C. Thévenin (Gentilly, France), S. Hardy (Gentilly, France), Y. Rétory (Gentilly, France), M. D'Ortho (Paris, France)
Unexpected large pressure increases during inspiration with new generation CPAP devices G. Liistro (Brussels, Belgium), M. Dury (Brussels, Belgium), V. Chantrain (Brussels, Belgium), G. Mwenge (Brussels, Belgium)
High rate of intolerance to ASV in patients with Cheynes-Stokes respiration (CSR) E. Mazzuca (Palermo, Italy), P. Baiamonte (Palermo, Italy), C. Gruttad'Auria (Palermo, Italy), M. Algeri (Palermo, Italy), C. Arena (Palermo, Italy), G. Linguanti (Palermo, Italy), A. Castrogiovanni (Solingen, Germany), M. Bonsignore (Palermo, Italy)
Impact of continuous or automatic positive airway pressure (CPAP/ APAP) pressure change on the apnoea-hypopnoea index (AHI): big data analysis J. Armitstead (Sydney, Australia), A. Malhotra (San Diego, United States of America), C. Nunez (San Diego, United States of America), J. Li (Singapore, Singapore), J. Pepin (Grenoble, France), P. Cistulli (Sydney, Australia), A. Benjafield (Sydney, Australia), H. Woehrle (Ulm, Germany)
The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA) C. Gunduz (Istanbul, Turkey), O. Basoglu (Izmir, Turkey), S. Schiza (Crete, Greece), J. Verbraecken (Antwerp, Belgium), P. Steiropoulos (Alexandroupolis, Greece), J. Kvamme (Førde, Norway), P. Joppa (Kosice, Slovakia), G. Roisman (Clamart, France), H. Hein (Reinbeck, Germany), G. Trakada (Athens, Greece), J. Hedner (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden)
The relationship between loop gain and respiratory regulation in Obstructive sleep apnea l. si (Tianjin, China), J. Cao (Tianjin, China), J. Zhang (Tianjin, China), B. Chen (Tianjin, China)
Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA M. Tasbakan (Izmir, Turkey), L. Grote (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden), J. Kvamme (Forde, Norway), J. Verbraecken (Antwerp, Belgium), W. Mcnicholas (Dublin, Ireland), G. Roisman (Clamart, France), R. Tkacova (Kosice, Slovakia), M. Bonsignore (Palermo, Italy), T. Saaresranta (Turku, Finland), P. Steiropoulos (Alexandroupolis, Greece), O. Basoglu (Izmir, Turkey)
A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis V. Phoophiboon (Bangkok, Thailand), N. Chirakalwasan (Bangkok, Thailand)
Pulmonary artery obstruction index and RV/LV ratio in patients with pulmonary embolism as a severity index risk factor for obstructive sleep apnea D. Magdy (Assuit, Egypt), A. Metwally (Assuit, Egypt), M. Makboul (Assuit, , Egypt), S. Farghaly (Assuit, Egypt)
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension G. Ernst (Buenos Aires, Argentina), M. Saban (Buenos Aires, Argentina), M. Schiavone (Buenos Aires, Argentina), M. Blanco (Buenos Aires, Argentina), S. Schonfeld (Buenos Aires, Argentina), A. Salvado (Buenos Aires, Argentina), E. Borsini (Buenos Aires, Argentina)
The effects of chronic intermittent hypoxia on dopaminergic neurodegeneration C. Liu (Taipei, Taiwan), C. Chen (Taipei, Taiwan), K. Ma (Taipei, Taiwan), Y. Lu (Taipei, Taiwan)